Albany, NY -- (SBWIRE) -- 05/01/2018 -- Flow Cytometry Market: Overview
Flow cytometry is an impedance or laser based biophysical technology which has applications in several fields such as protein engineering, biomarker detection, cell sorting, cell counting, cell analysis, etc. The global flow cytometry market was valued approximately US$ 3,072 Mn in 2016 and is anticipated to register CAGR of 11.0% from 2017 to 2025 to reach value of approximately US$ 8100 Mn by 2025. The reagents & consumables segment are likely to fuel expansion of the global flow cytometry market from 2017 to 2025.
Download PDF Brochure of Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40472
Flow cytometry analyzes fluid by suspending fluid in the light beam or laser beam. Cell components in the fluid are fluorescently labeled and then they are passed through beam which later on excited by the laser to emit light at diversified wavelengths. The fluorescence lights help to determine various properties of single particles and cells from different wavelengths. Flow cytometer analyzes up to thousands of particles per second as the beam passes through the liquid stream. Flow cytometry includes several products and services such as reagents & consumables, flow cytometry instruments, software’s and services. Reagents & consumables are useful for the perfect run of the flow cytometry instruments. Several reagent kits are available in market for specified application of fluorescence tagged antibodies used in several fields in industries and researches. Reagents & consumables includes clinical diagnostic reagents, fluorescent dyes & labeling, immunochemical reagents, sourcing reagents and amongst others. Demand of flow cytometry in the diagnosis of systemic diseases has increased in past decades. Growing prevalence of chronic diseases such as cancer, immunological diseases such as HIV/AIDS, hematological diseases and amongst others driving the flow cytometry market growth. However competition from image analyzer & scanning cytometers and lack of awareness are some restraints in the market growth.
Request to View Sample of Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40472
Flow cytometry market is in the growth stage. Key market players such as, Becton, Dickinson and Company, Merck KGaA, Beckman Coulter, Inc. (Danaher Corporation) and Thermo Fisher Scientific have strong presence in the global flow cytometer market. Established players continuously focus on increasing their research and development activities to come up with new products and attract more number of customers by offering innovative and technologically advanced products. For example, in 2016, Becton, Dickinson and Company spent US$ 828 Mn on research and development (31% higher than that in 2015). The company majorly invests its research and development for the development of flow cytometry instruments. In addition, rise in usage flow cytometry instruments offer ample business opportunities for the development of cutting edge technologies that promote credibility and encourage product uptake. Thus, rigorous investment in research and development activities for new product development and enhancement of existing product portfolio would help the key players to retain and enhance their share in the global flow cytometry market
The global flow cytometry market has been segmented based on technology, product & services, application, end-user, and geography. Among technology, bead-based segment is projected to lead the market and is expected to continue its dominance during the forecast period followed by cell-based segment. Bead-based flow cytometry is advanced technique for the cell sorting, cell analysis. Market of the segment is increasing due to the preference by the researchers in the developed countries. Among product & services, flow cytometry instruments segment was the leading revenue generating segment in 2016 and it is likely to continue its dominance during the forecast period. Software segment of indication is likely to lose its market share during the forecast period. Pharmaceutical & drug discovery segment is expected to continue its dominance in application segment in 2025. Among various, end-user, hospitals & diagnostic labs was the leading distribution channel in 2016 and is likely to account for leading share during the forecast period.
Geographically, North America captured lion’s share of global flow cytometry market in 2016. Increase government initiatives in research studies for the prevalence of disease boosting the market growth in the U.S. Asia Pacific market is projected to gain market share during the forecast period and is likely to be key revenue generator in the coming years. Increased prevalence rate of cancer and HIV in country increasing use of flow cytometry in drug discovery and development driving the market growth in Brazil, South Africa Saudi Arabia, etc. is likely to boost market growth in Latin America and Middle East & Africa.
Request to View Discount –
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=40472
Key companies operating in the global flow cytometry market and profiled in the report include Sysmex Partec GmbH, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Merck KGaA, Thermo Fisher Scientific, Inc. among others. These players are adopting advanced techniques in development of flow cytometry products to expand their product offerings, strengthen their geographical reach, increase customer base and garner market share. For instance, In January 2018, Cancer Genetics, Inc. announced to expand its immuno-oncology (IO) panel to new advanced IO panel as Complete::IO (include 5 new IO markers), by using most all-inclusive flow-cytometry-based biomarker panel of the industry. In another instance, In October 2017 Sysmex America Inc. introduced CyFlow Antibodies for the application in clinical flow cytometry.